AssuredPartners Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Buy
742
+47
+7% +$15.4K 0.02% 365
2025
Q4
$244K Buy
+695
New +$235K 0.04% 302
2025
Q2
Sell
-1,110
Closed -$483K 273
2025
Q1
$483K Buy
1,110
+23
+2% +$9.23K 0.09% 203
2024
Q4
$401K Buy
+1,087
New +$455K 0.08% 224

Other funds holding ELV

AssuredPartners Investment Advisors's ELV Position: Q1 2026 in Review

AssuredPartners Investment Advisors increased its Elevance Health (ELV) stake by 6.8% in Q1 2026, buying an estimated $15.4K and bringing the position to 742 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #365.

AssuredPartners Investment Advisors first reported a position in ELV in Q4 2024 and has held it in 4 quarters since. The position peaked at $483K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • AssuredPartners Investment Advisors held 742 shares of Elevance Health worth $225K as of Q1 2026.
  • AssuredPartners Investment Advisors bought 47 Elevance Health shares in Q1 2026, an estimated $15.4K.
  • Elevance Health made up 0.02% of AssuredPartners Investment Advisors's portfolio in Q1 2026, its #365 holding.
  • AssuredPartners Investment Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 4 quarters since.
  • AssuredPartners Investment Advisors's Elevance Health position peaked at $483K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.